Immunic, Inc. (IMUX)
13.11
+0.35
(+2.74%)
USD |
NASDAQ |
Sep 04, 16:00
12.85
-0.26
(-1.98%)
After-Hours: 20:00
Immunic SG&A Expense (TTM) : 27.24M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.24M |
| March 31, 2026 | 23.56M |
| December 31, 2025 | 21.24M |
| September 30, 2025 | 21.00M |
| June 30, 2025 | 19.38M |
| March 31, 2025 | 18.15M |
| December 31, 2024 | 18.01M |
| September 30, 2024 | 18.09M |
| June 30, 2024 | 17.51M |
| March 31, 2024 | 16.86M |
| December 31, 2023 | 16.01M |
| September 30, 2023 | 15.53M |
| June 30, 2023 | 15.34M |
| March 31, 2023 | 15.56M |
| December 31, 2022 | 15.26M |
| September 30, 2022 | 14.98M |
| June 30, 2022 | 14.31M |
| March 31, 2022 | 13.67M |
| December 31, 2021 | 30.55M |
| September 30, 2021 | 30.22M |
| June 30, 2021 | 29.82M |
| March 31, 2021 | 28.62M |
| December 31, 2020 | 10.33M |
| September 30, 2020 | 9.48M |
| June 30, 2020 | 9.05M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.79M |
| December 31, 2019 | 14.52M |
| September 30, 2019 | 13.35M |
| June 30, 2019 | 11.67M |
| March 31, 2019 | 3.205M |
| December 31, 2018 | 6.233M |
| September 30, 2018 | 9.833M |
| June 30, 2018 | 12.39M |
| March 31, 2018 | 14.59M |
| December 31, 2017 | 13.31M |
| September 30, 2017 | 11.69M |
| June 30, 2017 | 11.51M |
| March 31, 2017 | 11.48M |
| December 31, 2016 | 11.22M |
| September 30, 2016 | 11.32M |
| June 30, 2016 | 11.24M |
| March 31, 2016 | 12.08M |
| December 31, 2015 | 12.35M |
| September 30, 2015 | 12.41M |
| June 30, 2015 | 12.29M |
| March 31, 2015 | 11.27M |
| December 31, 2014 | 10.86M |
| September 30, 2014 | 10.33M |
| June 30, 2014 | 10.77M |
| March 31, 2014 | 10.78M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 620.29M |
| Sionna Therapeutics, Inc. | 37.45M |
| Alnylam Pharmaceuticals, Inc. | 1.318B |
| Anika Therapeutics, Inc. | 52.67M |
| Savara, Inc. | 56.71M |